EYE
National Vision Holdings, Inc.NasdaqResearch view
Healthcare · Ophthalmic Goods · SEC EDGAR FY 2026-01-03
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2026-01-03SectorHealthcare
Income$29.6M
Sales$2.0B
Book/sh$11.00
Cash/sh$0.51
Dividend TTM—
Payout0%
Employees—
IPO—
Quick Ratio0.33
Current Ratio0.55
Debt/Eq0.29
EPS (ttm)$0.37
EPS this Y202.8%
EPS past 3/5Y-10.7%
Sales past 3/5Y6.5%
EPS Y/Y TTM202.8%
Sales Y/Y TTM9.0%
Shs Outstand79.07M
ROA1.5%
ROE3.4%
ROIC3.9%
Gross Margin—
Oper. Margin3.0%
Profit Margin1.5%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$2.1B
2022
$1.6B
2022
$1.8B
2023
$1.8B
2024
$2.0B
2026
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2022 | FY2022 | FY2023 | FY2024 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $2.1B | $1.6B | $1.8B | $1.8B | $2.0B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $174.9M | $52.8M | $24.5M | $-10.4M | $58.8M |
| Net Income | $128.2M | $42.1M | $-65.9M | $-28.5M | $29.6M |
| Diluted EPS | $1.43 | $0.52 | $-0.84 | $-0.36 | $0.37 |
| Operating Cash Flow | $258.9M | $119.2M | $173.0M | $133.6M | $146.3M |
| Free Cash Flow | $163.4M | $5.7M | $58.3M | $38.1M | $73.5M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY26 cash-flow waterfall
Capital-light: capex is $72.8M against $146.3M operating cash
COMMUNITY · $EYE0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Ophthalmic Goods
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.